Michael J Fisher
Children's Hospital of Philadelphia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael J Fisher as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:07 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06161974 · Study of Olutasidenib and Temozolomide in HGGRigel Pharmaceuticals · recruiting · High Grade Glioma, Astrocytoma, Astrocytoma, Grade III · study chair
- Ph1NCT00716469 · Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform NeurofibromasChildren's Hospital of Philadelphia · terminated · Neurofibroma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Children's Tumor Foundation 2016 Neurofibromatosis (NF) ConferenceR13NS084619 · NINDS · CHILDREN'S TUMOR FOUNDATION · fiscal years 2016 · $20,000 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in diffuse midline glioma (dipg).